Harvard Bioscience (HBIO) Curent Deferred Tax Liability (2014 - 2015)

Harvard Bioscience (HBIO) reported Curent Deferred Tax Liability of $2.2 million for Q4 2015, up 1756.2% year-over-year from $121000.0 in Q4 2014, and up 820.49% quarter-over-quarter from $244000.0 in Q3 2015.

Harvard Bioscience (HBIO) Curent Deferred Tax Liability (2014 - 2015) Analysis & Trends

Harvard Bioscience (HBIO) has 2 years of Curent Deferred Tax Liability data on file, last reported at $2.2 million in Q4 2015.

  • Curent Deferred Tax Liability for Q4 2015 came in at $2.2 million, up 1756.2% year-over-year; the trailing twelve-month figure through Dec 2015 was $2.2 million (up 1756.2% YoY), and the FY2015 annual result was $2.2 million, up 1756.2% from the prior year.
  • Curent Deferred Tax Liability climbed to $2.2 million in Q4 2015 per HBIO's latest filing, from $244000.0 in the prior quarter.
  • Over five years, Curent Deferred Tax Liability peaked at $2.2 million in Q4 2015 and troughed at $121000.0 in Q4 2014.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Curent Deferred Tax (Qtr)
1 Intuitive Surgical 148.09 Bn 143.69 Bn 1.83 Bn -
2 Becton Dickinson 41.00 Bn 39.99 Bn 2.15 Bn -
3 Medline 30.38 Bn 36.22 Bn 1.84 Bn -
4 Resmed 28.22 Bn 26.56 Bn 890.98 Mn -
5 West Pharmaceutical Services 23.72 Bn 23.19 Bn 296.40 Mn -
6 Solventum 13.33 Bn 13.33 Bn 1.10 Bn -
7 Cooper Companies 13.12 Bn 12.99 Bn 735.40 Mn -
8 Align Technology 12.86 Bn 11.80 Bn 736.59 Mn -
9 Baxter International 10.51 Bn 8.47 Bn 891.00 Mn -
10 Harvard Bioscience 26.17 Mn 19.07 Mn 12.24 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2015 2.25 Mn
Dec 31, 2015 2.25 Mn
Sep 30, 2015 244,000.00
Sep 30, 2015 244,000.00
Jun 30, 2015 246,000.00
Jun 30, 2015 246,000.00
Mar 31, 2015 239,000.00
Mar 31, 2015 239,000.00
Dec 31, 2014 121,000.00
Dec 31, 2014 121,000.00